Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results.

Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J.

Med Care Res Rev. 2003 Sep;60(3):294-331. Review.

PMID:
12971231
2.

Interventions to improve follow-up of abnormal findings in cancer screening.

Bastani R, Yabroff KR, Myers RE, Glenn B.

Cancer. 2004 Sep 1;101(5 Suppl):1188-200. Review.

3.

Having a personal healthcare provider and receipt of adequate cervical and breast cancer screening.

Cardarelli R, Kurian AK, Pandya V.

J Am Board Fam Med. 2010 Jan-Feb;23(1):75-81. doi: 10.3122/jabfm.2010.01.090034.

4.

Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care.

Zapka J, Taplin SH, Price RA, Cranos C, Yabroff R.

J Natl Cancer Inst Monogr. 2010;2010(40):58-71. doi: 10.1093/jncimonographs/lgq009. Review.

5.

Implementing recommendations for the early detection of breast and cervical cancer among low-income women.

Lawson HW, Henson R, Bobo JK, Kaeser MK.

MMWR Recomm Rep. 2000 Mar 31;49(RR-2):37-55.

6.

A framework for improving the quality of cancer care: the case of breast and cervical cancer screening.

Zapka JG, Taplin SH, Solberg LI, Manos MM.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):4-13. Review.

7.

Quality assurance through quality improvement and professional development in the National Breast and Cervical Cancer Early Detection Program.

Siegl EJ, Miller JW, Khan K, Harris SE.

Cancer. 2014 Aug 15;120 Suppl 16:2584-90. doi: 10.1002/cncr.28822.

8.

Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.

Henley SJ, King JB, German RR, Richardson LC, Plescia M; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2010 Nov 26;59(9):1-25.

9.

Family planning provider referral, facilitation behavior, and patient follow-up for abnormal Pap smears.

Felix HC, Bronstein J, Bursac Z, Stewart MK, Foushee HR, Klapow J.

Public Health Rep. 2009 Sep-Oct;124(5):733-44.

10.

Are patterns of health behavior associated with cancer screening?

Meissner HI, Yabroff KR, Dodd KW, Leader AE, Ballard-Barbash R, Berrigan D.

Am J Health Promot. 2009 Jan-Feb;23(3):168-75. doi: 10.4278/ajhp.07082085.

PMID:
19149421
11.

Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening.

Yabroff KR, Kerner JF, Mandelblatt JS.

Prev Med. 2000 Oct;31(4):429-39.

PMID:
11006069
12.

The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.

Hsia J, Kemper E, Kiefe C, Zapka J, Sofaer S, Pettinger M, Bowen D, Limacher M, Lillington L, Mason E.

Prev Med. 2000 Sep;31(3):261-70.

PMID:
10964640
13.

Breast and cervical cancer screening interventions: an assessment of the literature.

Meissner HI, Breen N, Coyne C, Legler JM, Green DT, Edwards BK.

Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):951-61. Review.

14.

Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.

Goldzweig CL, Parkerton PH, Washington DL, Lanto AB, Yano EM.

Am J Manag Care. 2004 Apr;10(4):265-72.

15.
16.

Integrating mental health screening and abnormal cancer screening follow-up: an intervention to reach low-income women.

Ell K, Vourlekis B, Nissly J, Padgett D, Pineda D, Sarabia O, Walther V, Blumenfield S, Lee PJ.

Community Ment Health J. 2002 Aug;38(4):311-25.

PMID:
12166918
17.

Computational modeling and multilevel cancer control interventions.

Morrissey JP, Lich KH, Price RA, Mandelblatt J.

J Natl Cancer Inst Monogr. 2012 May;2012(44):56-66. doi: 10.1093/jncimonographs/lgs014.

18.

Strategies for follow-up and treatment services in state breast and cervical cancer screening programs.

Lantz PM, Richardson LC, Macklem DJ, Shugarman LR, Knutson DB, Sever LE.

Womens Health Issues. 1999 Jan-Feb;9(1):42-9.

PMID:
9949695
19.

Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.

Ramachandran A, Snyder FR, Katz ML, Darnell JS, Dudley DJ, Patierno SR, Sanders MR, Valverde PA, Simon MA, Warren-Mears V, Battaglia TA; Patient Navigation Research Program Investigators..

Cancer. 2015 Nov 15;121(22):4016-24. doi: 10.1002/cncr.29607.

20.

Public health national approach to reducing breast and cervical cancer disparities.

Miller JW, Plescia M, Ekwueme DU.

Cancer. 2014 Aug 15;120 Suppl 16:2537-9. doi: 10.1002/cncr.28818.

Items per page

Supplemental Content

Support Center